Coya Therapeutics, Inc. COYA
2.81 USD -0.27 (-8.77%)
At closeNov 5, 2026, 4:00 PM EST
3.54 +0.73 +25.80%
After hours · Nov 5, 4:00 PM ET
2.74 Day range 3.14
2.81 52-week range 6.51
- YTD
- -51.55%
- 1 year
- -51.30%
Financial health
Altman Z-Score
7.30 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -4.6×
FY 2020 5y median -5.8× FY 2025
P/S 12.2×
FY 2020 5y median 12.2× FY 2025
P/B 2.3×
FY 2020 5y median 2.2× FY 2025
P/FCF -9.0×
FY 2020 5y median -7.5× FY 2025
EV/EBITDA -2.4×
FY 2020 5y median -5.3× FY 2025
EV/Sales 6.3×
FY 2020 5y median 6.3× FY 2025
FCF Yield -11.1%
FY 2020 5y median -13.4% FY 2025
Profitability
Gross Margin 99.7%
FY 2020 5y median 0.0% FY 2025
Operating Margin -255.0%
FY 2020 5y median -131.7% FY 2025
Net Margin -267.1%
FY 2020 5y median -133.1% FY 2025
ROE -49.3%
FY 2020 5y median -37.6% FY 2025
ROIC -46.0%
FY 2020 5y median -46.0% FY 2025
ROA -42.5%
FY 2020 5y median -42.5% FY 2025
Growth (YoY)
Revenue 123.6%
FY 2020 FY 2025
Operating Income -17.5%
FY 2020 FY 2025
EPS (diluted) -29.6%
FY 2020 FY 2025
Free Cash Flow -4.4%
FY 2020 FY 2025
Financial Health
Current Ratio 8.5×
FY 2020 5y median 8.2× FY 2025
Quick Ratio 8.5×
FY 2020 5y median 8.2× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 2.2×
FY 2020 5y median 2.2× FY 2025
Interest Coverage 0.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31